Trial
NCT05856526
A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Netherton Syndrome
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Boehringer Ingelheim
Collaborators
—
Condition
Netherton Syndrome
Intervention
Spesolimab - solution for infusion
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-03-12